![]()
|
|
||||||||
JBC, Vol. 250, Issue 11, 4246-4252, Jun, 1975
M. C. Lin, Y. Salomon, M. Rendell and M. Rodbell
The kinetic characteristics of substrate utilization by hepatic adenylate
cyclase were investigated under a variety of incubation conditions,
including veriations in pH, [substrate], [Mg2+], and in the absence or
presence of glucagon. Activities were compared with ATP and
5'-adenylylimidodiphosphate (App(NH)p) as substrates. The Km for both
substrates was about 50 muM; Vmax given with App(NH)p was about 40% lower
than obtained with ATP as substrate. In the presence of a saturating
concentration of substrate (1 mM), basal activity was increased 4-fold by
increasing [Mg2+] from 5 to 50 mM. The stimulatory effect of Mg2+ was not
due to an allosteric action since basal activity was only marginally
enhanced (40%) when the substrate concentration was reduced to 10 muM. As
suggested by deHaen ((1974 J. Biol. Chem. 249, 2756), it is likely that
Mg2+ increases enzyme activity by decreasing the concentration of an
inhibitory, unchelated form of substrate that competes with the productive
magnesium-substrate complex at the active site. Activity-pH profiles
differed with ATP and App(NH)p as substrates; a shift in pH optimum was
observed which correlated with the different pKa of the terminal phosphate
groups of ATP and App(nh)p, and which reflect the concentration of
protonated substrate (ATPH-3 minus) present in the incubation medium.
Accordingly, protonated substrate is the predominant inhibitory species of
unchelated substrate and probably has a considerably higher affinity for
the active site than does the magnesium-substrate complex.
Glucagon-stimulated activity was less susceptible to inhibition by
protonated substrate than is the basal state as evidenced by lower
stimulatory effect when the [Mg2+] was increased from 5 to 20 mM. However,
increasing the [Mg2+] from 20 to 50 mM resulted in marked inhibition of
glucagon-stimulated activity, particularly in the presence of 10 muM
substrate. Conversely, at a fixed [Mg2+], concentrations of substrate at
least 20-fold higher than the Km were required to achieve maximal
hormone-stimulated activity. These findings suggest that the unchelated,
fully ionized form of substrate serves as an activating ligand, as has been
observed with guanine nucleotides at considerably lower concentrations.
Thus, Mg2+ affects adenylate cyclase activity by forming the productive
substrate complex and by titrating the inhibitory protonated and activating
free forms of substrate. As a result of these effects of unchelated
substrate, it proved difficult to evaluate the kinetic parameters involved
in substrate binding and utilization and the effects of hormone thereon
when substrate was added as the only source of activating ligand. However,
linear Michaelis kinetic data were obtained by adding the activating ligand
5'-guanylylimidodiphosphate with glucagon and by making appropriate
adjustments of pH and [Mg2+]. Vmax was increased 4-fold without changes in
Km by the actions of 5'-guanylylimidodiphosphate and glucagon.
The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Willoughby and D. M. F. Cooper Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains Physiol Rev, July 1, 2007; 87(3): 965 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby, N. Masada, A. J. Crossthwaite, A. Ciruela, and D. M. F. Cooper Localized Na+/H+ Exchanger 1 Expression Protects Ca2+-regulated Adenylyl Cyclases from Changes in Intracellular pH J. Biol. Chem., September 2, 2005; 280(35): 30864 - 30872. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hu, H. Nakata, C. Gu, T. de Beer, and D. M. F. Cooper A Critical Interplay between Ca2+ Inhibition and Activation by Mg2+ of AC5 Revealed by Mutants and Chimeric Constructs J. Biol. Chem., August 30, 2002; 277(36): 33139 - 33147. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Burcelin, C. Mrejen, J. F. Decaux, S. H. De Mouzon, J. Girard, and M. J. Charron In Vivo and in Vitro Regulation of Hepatic Glucagon Receptor mRNA Concentration by Glucose Metabolism J. Biol. Chem., April 3, 1998; 273(14): 8088 - 8093. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |